Scpharmaceuticals Stock Price History
| SCPH Stock | USD 4.94 0.08 1.65% |
Below is the normalized historical share price chart for Scpharmaceuticals extending back to November 17, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Scpharmaceuticals stands at 4.94, as last reported on the 19th of July, with the highest price reaching 5.03 and the lowest price hitting 4.84 during the day.
If you're considering investing in Scpharmaceuticals Stock, it is important to understand the factors that can impact its price. Scpharmaceuticals is risky given 3 months investment horizon. Scpharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.22, which indicates the firm had a 0.22 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.2% are justified by taking the suggested risk. Use Scpharmaceuticals Semi Deviation of 2.82, risk adjusted performance of 0.2066, and Coefficient Of Variation of 470.74 to evaluate company specific risk that cannot be diversified away.
As of now, Scpharmaceuticals' Stock Based Compensation To Revenue is decreasing as compared to previous years. . As of now, Scpharmaceuticals' Price Book Value Ratio is increasing as compared to previous years. The Scpharmaceuticals' current Price To Book Ratio is estimated to increase to 12.42, while Price To Sales Ratio is projected to decrease to 4.12. Scpharmaceuticals Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of November 2017 | 200 Day MA 3.4658 | 50 Day MA 3.5733 | Beta 0.361 |
Scpharmaceuticals | Build AI portfolio with Scpharmaceuticals Stock |
Sharpe Ratio = 0.2229
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SCPH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.37 actual daily | 48 52% of assets are more volatile |
Expected Return
| 1.2 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Scpharmaceuticals is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scpharmaceuticals by adding it to a well-diversified portfolio.
Price Book 28.4488 | Enterprise Value Ebitda (6.69) | Price Sales 6.212 | Shares Float 31.6 M | Wall Street Target Price 15.6 |
Scpharmaceuticals Stock Price History Chart
There are several ways to analyze Scpharmaceuticals Stock price data. The simplest method is using a basic Scpharmaceuticals candlestick price chart, which shows Scpharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 18, 2025 | 4.94 |
| Lowest Price | May 14, 2025 | 2.24 |
Scpharmaceuticals July 19, 2025 Stock Price Synopsis
Various analyses of Scpharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Scpharmaceuticals Stock. It can be used to describe the percentage change in the price of Scpharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Scpharmaceuticals Stock.| Scpharmaceuticals Accumulation Distribution | 15,210 | |
| Scpharmaceuticals Price Daily Balance Of Power | 0.42 | |
| Scpharmaceuticals Price Action Indicator | 0.05 | |
| Scpharmaceuticals Price Rate Of Daily Change | 1.02 |
Scpharmaceuticals July 19, 2025 Stock Price Analysis
Scpharmaceuticals Stock Price History Data
The price series of Scpharmaceuticals for the period between Sun, Apr 20, 2025 and Sat, Jul 19, 2025 has a statistical range of 2.7 with a coefficient of variation of 22.18. The price distribution for the period has arithmetic mean of 3.45. The median price for the last 90 days is 3.81.| Open | High | Low | Close | Volume | ||
| 07/18/2025 | 4.85 | 5.03 | 4.84 | 4.94 | 402,668 | |
07/17/2025 | 4.51 | 4.89 | 4.51 | 4.86 | 476,323 | |
07/16/2025 | 4.44 | 4.55 | 4.43 | 4.53 | 256,104 | |
| 07/15/2025 | 4.50 | 4.57 | 4.36 | 4.39 | 214,106 | |
07/14/2025 | 4.36 | 4.51 | 4.31 | 4.48 | 299,431 | |
07/11/2025 | 4.48 | 4.57 | 4.38 | 4.38 | 336,245 | |
07/10/2025 | 4.04 | 4.54 | 3.96 | 4.47 | 547,112 | |
| 07/09/2025 | 3.99 | 4.18 | 3.99 | 4.08 | 264,990 | |
07/08/2025 | 3.89 | 3.98 | 3.88 | 3.96 | 187,577 | |
07/07/2025 | 3.94 | 3.99 | 3.83 | 3.86 | 179,364 | |
07/03/2025 | 4.04 | 4.14 | 3.97 | 3.97 | 184,541 | |
07/02/2025 | 3.93 | 4.08 | 3.86 | 4.04 | 318,029 | |
07/01/2025 | 3.80 | 3.99 | 3.78 | 3.92 | 259,108 | |
06/30/2025 | 3.88 | 3.93 | 3.77 | 3.81 | 284,831 | |
06/27/2025 | 3.99 | 3.99 | 3.82 | 3.87 | 688,057 | |
06/26/2025 | 3.98 | 4.03 | 3.84 | 3.98 | 162,291 | |
06/25/2025 | 3.99 | 4.00 | 3.88 | 3.97 | 137,483 | |
06/24/2025 | 3.88 | 3.97 | 3.85 | 3.96 | 185,627 | |
06/23/2025 | 3.84 | 3.88 | 3.71 | 3.83 | 218,350 | |
06/20/2025 | 3.96 | 4.00 | 3.76 | 3.84 | 454,915 | |
06/18/2025 | 3.99 | 4.02 | 3.87 | 3.92 | 140,105 | |
06/17/2025 | 4.00 | 4.17 | 3.89 | 3.99 | 242,712 | |
06/16/2025 | 4.01 | 4.06 | 3.91 | 3.99 | 301,137 | |
06/13/2025 | 3.92 | 4.06 | 3.86 | 3.95 | 211,100 | |
06/12/2025 | 4.06 | 4.18 | 3.97 | 4.00 | 218,163 | |
06/11/2025 | 4.29 | 4.37 | 4.05 | 4.08 | 308,182 | |
06/10/2025 | 4.25 | 4.40 | 4.18 | 4.27 | 235,636 | |
06/09/2025 | 4.27 | 4.29 | 4.16 | 4.25 | 189,768 | |
06/06/2025 | 4.17 | 4.36 | 4.08 | 4.20 | 424,761 | |
| 06/05/2025 | 4.12 | 4.29 | 4.06 | 4.11 | 627,244 | |
06/04/2025 | 3.85 | 4.15 | 3.83 | 4.12 | 362,263 | |
06/03/2025 | 3.79 | 3.98 | 3.76 | 3.85 | 288,629 | |
06/02/2025 | 3.66 | 3.88 | 3.56 | 3.84 | 346,929 | |
05/30/2025 | 3.52 | 3.69 | 3.42 | 3.64 | 288,816 | |
05/29/2025 | 3.63 | 3.72 | 3.51 | 3.55 | 307,809 | |
05/28/2025 | 3.54 | 3.74 | 3.45 | 3.58 | 242,271 | |
| 05/27/2025 | 3.40 | 3.60 | 3.23 | 3.54 | 291,959 | |
05/23/2025 | 3.42 | 3.47 | 3.30 | 3.31 | 284,049 | |
05/22/2025 | 3.37 | 3.57 | 3.32 | 3.51 | 272,042 | |
05/21/2025 | 3.23 | 3.37 | 3.20 | 3.34 | 386,047 | |
05/20/2025 | 3.52 | 3.54 | 3.19 | 3.29 | 481,632 | |
05/19/2025 | 3.19 | 3.54 | 3.09 | 3.52 | 767,494 | |
| 05/16/2025 | 2.93 | 3.39 | 2.89 | 3.22 | 1,202,096 | |
| 05/15/2025 | 2.20 | 3.00 | 2.20 | 2.88 | 1,691,391 | |
| 05/14/2025 | 2.34 | 2.39 | 2.23 | 2.24 | 630,862 | |
05/13/2025 | 2.48 | 2.48 | 2.29 | 2.32 | 399,624 | |
05/12/2025 | 2.45 | 2.49 | 2.35 | 2.48 | 291,086 | |
05/09/2025 | 2.47 | 2.61 | 2.42 | 2.44 | 149,928 | |
| 05/08/2025 | 2.41 | 2.54 | 2.38 | 2.51 | 106,945 | |
05/07/2025 | 2.29 | 2.43 | 2.26 | 2.41 | 170,035 | |
05/06/2025 | 2.46 | 2.55 | 2.26 | 2.29 | 270,468 | |
05/05/2025 | 2.58 | 2.64 | 2.47 | 2.48 | 81,863 | |
05/02/2025 | 2.56 | 2.63 | 2.50 | 2.60 | 156,493 | |
| 05/01/2025 | 2.56 | 2.58 | 2.46 | 2.53 | 190,748 | |
04/30/2025 | 2.33 | 2.57 | 2.24 | 2.55 | 328,254 | |
04/29/2025 | 2.44 | 2.44 | 2.35 | 2.37 | 181,698 | |
04/28/2025 | 2.53 | 2.62 | 2.41 | 2.45 | 101,115 | |
04/25/2025 | 2.48 | 2.53 | 2.37 | 2.51 | 249,220 | |
04/24/2025 | 2.59 | 2.59 | 2.48 | 2.50 | 229,903 | |
04/23/2025 | 2.70 | 2.76 | 2.59 | 2.60 | 187,590 | |
04/22/2025 | 2.56 | 2.64 | 2.50 | 2.61 | 182,384 |
About Scpharmaceuticals Stock history
Scpharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Scpharmaceuticals is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Scpharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Scpharmaceuticals stock prices may prove useful in developing a viable investing in Scpharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 44.5 M | 24.8 M | |
| Net Loss | -33.2 M | -34.8 M |
Scpharmaceuticals Quarterly Net Working Capital |
|
Scpharmaceuticals Stock Technical Analysis
Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Scpharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Scpharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Scpharmaceuticals Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Scpharmaceuticals to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2066 | |||
| Jensen Alpha | 0.8981 | |||
| Total Risk Alpha | 0.3698 | |||
| Sortino Ratio | 0.2807 | |||
| Treynor Ratio | 0.6999 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |